Interestingly, S100A9 expression is enhanced in serum and pancreatic islet of T1DM humans; due to the known pro-inflammatory actions of S100A9, this effect is thought to contribute to disease progression30,31. Here, S100A9 is linked to type 1 diabetes mellitus.